New family of persona-tailored solutions uses the power of CARAai and the unique depth and detail of ConcertAI’s Oncology Data to deliver enterprise-wide value to
Cloud-based, innovative, AI-powered technologies enable the streamlined delivery of leading clinical services and scaled operations in advanced Imaging ConcertAI‘s TeraRecon, a leader in integrating advanced
CARAai is the Leading Multi-Modal Oncology Data Cloud and Platform for a Suite of AI SaaS Solutions with NVIDIA NIM Microservices Fine-Tuned with Oncology Data
DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. and ConcertAI’s TeraRecon, a leader in medical imaging
Exigent Research and ConcertAI announced a major multi-year partnership to assure potentially lifesaving clinical trials are available to the broadest population of patients possible, combining
ConcertAI and NeoGenomics announce a joint AI SaaS solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization. CTO-H provides a research
Fuel up with free Health Tech Insights
